CVS Equine practices are undertaking a collaborative clinical study to improve our understanding about the clinical signs and aetiology of equine pastern dermatitis (EPD).

Despite being a common disease, CVS says very little research has been undertaken into EPD in the UK.

In addition, numerous different treatments are currently used for EPD, for which there is not always robust scientific evidence.

The CVS study, which started in 2022 and will continue till early 2024, involves 20 practices.

Samples have been collected from over 70 cases from horses that have been diagnosed by EPD throughout the UK.

Full blood profiles have been assessed, in addition to bacterial culture analysis of the lesions, PCR analysis for dermatophytes (ringworm fungi), microscopy for ectoparasites (mites) and skin cytology.

An owner questionnaire has also been completed to gather information on EDP management.

Each horse’s lesions have been graded and descriptive data relating to the lesions were recorded.

Data collection is now complete and a team of researchers, led by vet Manuela Diaz Ramos, has started analysing the data.

A full report on the findings, along with treatment and management recommendations, is expected to be presented at a scientific conference later this year. 

PS: Whilst you're here, take a moment to see our latest job opportunities for vet nurses.